Articles

KoSyne NeuroTech Completes Pre-A Round to Accelerate Clinical Translation of Brain-Computer Interface Neuromodulation Platform | Tong's Family

KoSyne NeuroTech Completes Pre-A Round to Accelerate Clinical Translation of Brain-Computer Interface Neuromodulation Platform | Tong's Family

Recently, **KoSyne NeuroTech** (hereinafter referred to as "KoSyne NeuroTech"), a **Dongtou Family company** specializing in non-invasive brain-computer interfaces and neuromodulation, announced the completion of its **Pre-A funding round** — another key milestone following Dongtou Capital's exclusive angel round investment. **This round was led exclusively by Yunqi Capital, with the proceeds to be used primarily for core technology R&D, clinical translation, and global expansion.**